What amount sold does Human Intel Institute report in Form D filings?

The latest linked filings report $35K sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Human Intel Institute's most recent SEC filing?

Human Intel Institute's most recent Form D filing was on 2025-10-10.

How many investors does Human Intel Institute have?

The most recent Form D filing lists 2 investor(s).

Human Intel Institute

CIK: 0002023181·Other Technology·PORTLAND, OR·Corporation·Founded 2024

Reported Sold

$35,000

Total Filings

Identified Offerings

Last Filed

Oct 10, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Technology industry

SEC EDGAR

Offering filing timeline

Oct 10, 2025Form D — New notice

Reported sold: $15,000 · Target: $4,500,000

Rule 506(b)·2 investors

May 16, 2025Form D/A — Amendment

Reported sold: $20,000 · Target: $2,500,000

Rule 506(b)·2 investors

Changed: Reported amount sold, Reported investors

May 16, 2024Form D — New notice

Reported sold: $10,000 · Target: $2,500,000

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

33%

Latest reported sold across 2 identified offerings

$35,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Ned Hayes

Related Person

Appears on 3 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Oct 10, 2025	New	$4,500,000	$15,000	2
May 16, 2025	Amendment	$2,500,000	$20,000	2
May 16, 2024	New	$2,500,000	$10,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Araceli Biosciences Inc.

Other Technology

Offering target: $4,500,000

Filed Nov 3, 2026